PMID: 698907Sep 1, 1978Paper

The significance of mediastinal involvement in early stage Hodgkin's disease

Cancer
P MauchS Hellman

Abstract

Between April 1969, and December 1974, 111 consecutive surgically staged I A and II A patients with supradiaphragmatic Hodgkin's disease were treated at the Joint Center for Radiation Therapy. Patients received 3600--4400 rad to mantle and para-aortic--splenic pedicle regions. Median follow-up was 56 months (30--96). Fourteen patients developed relapsing Hodgkin's disease and three patients died of possible treatment-related causes, two with acute myocardial infarctions and one with radiation pneumonitis. Patients with mediastinal enlargement greater than one third of the chest diameter have a significantly higher risk (p less than 0.01) of developing relapse (9 of 18) than patients with lesser or no mediastinal disease (5 of 93). Of the 18 patients with large mediastinal disease, six relapsed in the mediastinum and two in the lung. There continue to be no pelvic extensions in the entire group. There is a 92% relapse-free and 97% overall survival in the 93 patients without extensive mediastinal disease. We continue to recommend mantle and para-aortic--splenic pedicle irradiation for these patients. In view of the large number of relapses in patients with extensive mediastinal disease, we are now treating this subgroup of patien...Continue Reading

References

Jan 1, 1976·AJR. American Journal of Roentgenology·J M VaethJ P Green
Mar 1, 1976·International Journal of Radiation Oncology, Biology, Physics·A J PiroS Hellman
Jul 10, 1975·The New England Journal of Medicine·W D Bloomer, S Hellman
Jan 1, 1973·Revue Roumaine De Médecine Interne·M GociuS Berceanu
Jun 1, 1974·Cancer·A R Keller, B Castleman
Dec 1, 1958·Journal of Chronic Diseases·S J CUTLER, F EDERER

❮ Previous
Next ❯

Citations

Oct 7, 2004·Annals of Nuclear Medicine·Emel Ceylan GunayBiray Caner
Oct 12, 2012·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·J KrizH T Eich
Oct 1, 1989·International Journal of Radiation Oncology, Biology, Physics·R FarahR R Weichselbaum
May 1, 1996·International Journal of Radiation Oncology, Biology, Physics·J D NaidaA S Lichter
Nov 10, 2000·International Journal of Radiation Oncology, Biology, Physics·J H ElconinL R Prosnitz
Dec 31, 2002·International Journal of Radiation Oncology, Biology, Physics·Gregory M ChronowskiJames D Cox
Oct 6, 1997·International Journal of Radiation Oncology, Biology, Physics·L Hughes-DaviesP M Mauch
Sep 1, 1989·Clinical Oncology : a Journal of the Royal College of Radiologists·S ScheyG Vaughan Hudson
Mar 1, 1987·Baillière's Clinical Haematology·S B Sutcliffe, A R Timothy
Jun 23, 2000·Critical Reviews in Oncology/hematology·H EghbaliP Richaud
Mar 2, 2002·European Journal of Haematology·T P VassilakopoulosG A Pangalis
Nov 29, 1979·The New England Journal of Medicine·J F DesforgesA Piro
Mar 5, 1992·The New England Journal of Medicine·W J Urba, D L Longo
Feb 25, 1993·The New England Journal of Medicine·V T DeVita, S M Hubbard
Feb 1, 1991·Australian and New Zealand Journal of Medicine·K H LiewI A Cooper
Feb 1, 1985·Postgraduate Medical Journal·T A Lister
Oct 29, 2004·Upsala Journal of Medical Sciences·Daniel Molin
Jan 1, 1983·Cancer Investigation·T J Kinsella, E Glatstein
Jan 1, 1984·The American Journal of the Medical Sciences·M Markman
Oct 1, 1983·International Journal of Radiation Oncology, Biology, Physics·R A RostockS E Order
May 1, 1982·International Journal of Radiation Oncology, Biology, Physics·W B Mill, F A Lee
Nov 15, 1994·International Journal of Radiation Oncology, Biology, Physics·M ZaniniR Zucali
Oct 1, 1979·Clinics in Haematology·S B SutcliffeT A Lister
Oct 1, 1979·Clinics in Haematology·J S GreenbergerR R Weichselbaum
Sep 1, 1986·The Annals of Thoracic Surgery·B Mullen, J D Richardson
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·M K GospodarowiczT Chua
Feb 1, 1980·International Journal of Radiation Oncology, Biology, Physics·A R TimothyA E Jones
Mar 1, 1989·International Journal of Radiation Oncology, Biology, Physics·J M MefferdM P Link
Jul 1, 1988·International Journal of Radiation Oncology, Biology, Physics·K L ScheweJ D Cox
Jun 15, 1993·International Journal of Radiation Oncology, Biology, Physics·C FerméC Gisselbrecht
May 15, 1991·International Journal of Radiation Oncology, Biology, Physics·A P BrownJ W Wong
Sep 30, 1993·International Journal of Radiation Oncology, Biology, Physics·R A Behar
Feb 1, 1990·International Journal of Radiation Oncology, Biology, Physics·N J TarbellP Mauch
Sep 1, 1990·International Journal of Radiation Oncology, Biology, Physics·C K LeeS H Levitt
Sep 1, 1990·International Journal of Radiation Oncology, Biology, Physics·W F HartsellR Weichselbaum

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.